The secret behind successful proximity ligation is careful preparation, with a special focus on antibody selection. Navinci, formerly known as Olink Biosciences, has a proud history as developers of the first commercial in situ proximity ligation assay, the Duolink assay (now sold to Sigma). The next-generation Naveni proximity ligation assays are based on a new, proprietary technology providing higher sensitivity and less unspecific background than traditional PLA. The developers of the Naveni technology are still actively working on new technology development in our R&D laboratory in Uppsala, which gives us the possibility to provide state-of-the-art technical support to our customers. Please contact us through the form below with any questions you might have before ordering, or after you have started your studies.